These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 962493)

  • 1. Correlation between plasma and cerebrospinal levels of imipramine.
    Sathananthan GL; Gershon S; Almeida M; Spector N; Spector S
    Arch Gen Psychiatry; 1976 Sep; 33(9):1109-10. PubMed ID: 962493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active metabolites of imipramine and desipramine in man.
    Potter WZ; Calil HM; Sutfin TA; Zavadil AP; Jusko WJ; Rapoport J; Goodwin FK
    Clin Pharmacol Ther; 1982 Mar; 31(3):393-401. PubMed ID: 7060321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imipramine and desipramine in plasma and spinal fluid: relationship to clinical response and serotonin metabolism.
    Muscettola G; Goodwin FK; Potter WZ; Claeys MM; Markey SP
    Arch Gen Psychiatry; 1978 May; 35(5):621-5. PubMed ID: 365126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of imipramine (IMI) and desmethylimipramine (DMI) and clinical response in prepubertal major depressive disorder: a preliminary report.
    Puig-Antich J; Perel JM; Lupatkin W; Chambers WJ; Shea C; Tabrizi MA; Stiller RL
    J Am Acad Child Psychiatry; 1979; 18(4):616-27. PubMed ID: 541469
    [No Abstract]   [Full Text] [Related]  

  • 5. Cerebrospinal fluid levels of amitriptyline, nortriptyline, imipramine and desmethylimipramine. Relationship to plasma levels and treatment outcome.
    Hanin I; Koslow SH; Kocsis JH; Bowden CL; Brunswick D; Frazer A; Carl J; Robins E
    J Affect Disord; 1985 Jul; 9(1):69-78. PubMed ID: 3160750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous depression and imipramine levels in the blood.
    Costa D; Predescu V; Vişan-Ionescu I; Ciurezu T
    Psychopharmacology (Berl); 1980; 70(3):291-4. PubMed ID: 6777803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of imipramine plasma levels for depressive illness.
    Glassman AH; Perel JM; Shostak M; Kantor SJ; Fleiss JL
    Arch Gen Psychiatry; 1977 Feb; 34(2):197-204. PubMed ID: 843179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Variations in the blood levels of imipramine and desmethylimipramine, depending upon the route of administration, intramuscular or oral, of Tofranil].
    Rigal J; Albin H; França X; Vinçon G; Démotes-Mainard F
    Ann Med Psychol (Paris); 1988; 146(8):764-72. PubMed ID: 3242402
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeting imipramine dose in children with depression.
    Sallee F; Stiller R; Perel J; Rancurello M
    Clin Pharmacol Ther; 1986 Jul; 40(1):8-13. PubMed ID: 3720179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of tricyclic antidepressants and clinical efficacy: review of the literature -- part II.
    Risch SC; Huey LY; Janowsky DS
    J Clin Psychiatry; 1979 Feb; 40(2):58-69. PubMed ID: 581671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable isotope coadministration methodology for the estimation of the fraction of imipramine metabolized to desipramine.
    Sasaki Y; Shinohara Y; Baba S
    J Pharm Sci; 1990 Feb; 79(2):96-8. PubMed ID: 2324970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-pass metabolism of imipramine and desipramine: impact of the sparteine oxidation phenotype.
    Brøsen K; Gram LF
    Clin Pharmacol Ther; 1988 Apr; 43(4):400-6. PubMed ID: 3356084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased plasma concentrations of imipramine and desipramine following cholestyramine intake in depressed patients.
    Spina E; Avenoso A; Campo GM; Caputi AP; Perucca E
    Ther Drug Monit; 1994 Aug; 16(4):432-4. PubMed ID: 7974637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated plasma tricyclic levels with therapeutic doses of imipramine.
    Garvey MJ; Tuason VB; Johnson RA; Valentine RH; Cooper TB
    Am J Psychiatry; 1984 Jul; 141(7):853-6. PubMed ID: 6731633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of steady-state imipramine and desmethylimipramine plasma concentrations from single-dose data.
    Brunswick DJ; Amsterdam JD; Mendels J; Stern SL
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):605-10. PubMed ID: 436362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of imipramine and desipramine in man after different routes of administration.
    Nagy A; Johansson R
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(2-3):145-60. PubMed ID: 1102994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The N-demethylation of imipramine correlates with the oxidation of S-mephenytoin (S/R-ratio). A population study.
    Skjelbo E; Gram LF; Brøsen K
    Br J Clin Pharmacol; 1993 Mar; 35(3):331-4. PubMed ID: 8471415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary desipramine hydroxylation index and steady-state plasma concentrations of imipramine and desipramine.
    Spina E; Arena A; Pisani F
    Ther Drug Monit; 1987 Jun; 9(2):129-33. PubMed ID: 3617150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excretion of imipramine and desipramine in human breast milk.
    Sovner R; Orsulak PJ
    Am J Psychiatry; 1979 Apr; 136(4A):451-2. PubMed ID: 426114
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma levels of imipramine in depression. Environmental and genetic factors.
    Perel JM; Mendlewicz J; Shostak M; Kantor SJ; Glassman AH
    Neuropsychobiology; 1976; 2(4):193-202. PubMed ID: 1012454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.